REGN Investing Cash Flow

Regeneron Pharmaceuticals · Investing Cash Flow

REGN logo

REGN Investing Cash Flow

Latest reported-$704.20M
REGN Cash from Investing (-$77.60M → -$704.20M)
High-resolution chart · PNG

REGN investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
-629,100,000
-2,468,100,000
-3,185,100,000
-3,784,600,000
-5,384,700,000
-70,600,000
-2,027,800,000
-1,463,000,000
-1,005,182,000
-1,046,904,000
-907,601,000
-420,777,000
-355,455,000
-81,073,000
128,471,000
-434,153,000
146,000
30,815,000
-85,723,000
-155,105,000
115,494,000
-4,583,000
-63,843,000
-58,516,000
-75,385,000
-57,676,000
17,500,000
2,400,000
-38,900,000
-44,300,000
7,400,000
31,900,000
-23,600,000
8,200,000
-77,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.